Yvonne Vercoulen Yvonne Vercoulen

Spatial omics identifies potential inflammatory risk factors for development of colitis-associated cancer in IBD

In our latest paper we used spatial transcriptomics and proteomics to identify specific risk factors at early stages of cancer development in patients with Inflammatory bowel disease (Crohn’s and Ulcerative colitis). Many patients undergo regular surveillance endoscopy, to remove any potential malignant growths. Besides this being a high burden for the patients, it remained unclear which inflammatory factors are responsible for the higher risk of cancer development. Hence complicating choices for treatment which could either reduce or worsen this risk. We identified elevated inflammatory factors, namely cytokines (IL17), signaling pathways (JAK-STAT signaling) in both epithelium and immune cells that were elevated only in patients that developed dysplasia. Since drugs for these pathways exist, future research should demonstrate whether such specific treatments benefit IBD patients at risk of cancer development by both reducing inflammation and preventing cancer development.. We thank the fantastic team of collaborators from the clinic, biostatistics, and multi-scale spatial omics platform. Congratulations to the team, especially Matthijs Baars and Evelien Floor and our partners in IBD research from the Oldenburg group.

We dedicate this to the memory of Neeraj Sinha, co-first author of this work.

Read More
Yvonne Vercoulen Yvonne Vercoulen

High Tumor- T cell distance differentiates metastatic colon cancers

In our study led by Matthijs Baars and Emre kucukkose, in close collaboration with the team of Onno Kranenburg and fantastic clinical collaborators from the Cancer center, we set out to uncover risk factors for colon cancer metastasis. We explored the tumor immune microenvironment of primary tumors from patients with MSI-colon cancers and compared tumors that either did or did not metastasize. We found that while cytotoxic T cells are present in simllar numbers, they locate completely different: In metastatic tumors the T cells localized far away from the tumor within the stromal region and showed no signs of activation, while in the non-metastatic tumors the T cells directly localized with the tumor cells. Of note, with funding from the Sacha Swarttouw-Hijmans foundation we are currently explanding the numbers of samples t to explore whether we can use this as a biomarker to predict risk of metastatsis with Dr. Jeanine Roodhart and Dr. Sjoerd Ellias. Read more in our published story at British Journal of Cancer

Read More
Yvonne Vercoulen Yvonne Vercoulen

What does LEGO have to do with our Research?

In honor of her appointment as Associate Professor this year, Yvonne Vercoulen recorded a 2-minute research pitch explaining why studying the spatial organization of cells in a tissue is important to comprehend disease development, progress and therapy response. Curious? Go to YouTube and turn on any language subtitles to watch it!

Read More
Yvonne Vercoulen Yvonne Vercoulen

Kick-off TOPGut MSCA-doctoral network

At TU Berlin we enjoyed a fantastic and fun kick-off event of the TOP GUT consortium. With tthe aim to develop Gut-on-a-Chip systems incorporating all facets relevant in cancer development and chronic disease, ideas and plans were actively discussed. Faranak Heidari presented her project at the Utrecht University with Dr. Silvia Mihaila and Roos Masereeuw in collaboration with the Vercoulen lab where she will engineer crypt-villi patterns in a gut-barrier on a chip system using organoids.. This project will promote availability of in vitro models to study immune-epitheilial, microbiome-, and epitheilial-stromal interactions, as well as permeability and absorption of the mucosal barrier in cancer and Inflammatory Bowel Disease and test mechanisms of therapy response vs resistance. We are excited to start working in this exciting consortium and push the limits to improve in vitro model systems.

Read More
Yvonne Vercoulen Yvonne Vercoulen

In our memories: Neeraj Sinha

With great sadness we say farewell to our gentle-hearted and cheerful former colleague Neeraj Sinha. He worked with us as a postdoc and made valuable contribution to multiple research projects. We are grateful to have had the pleasure to work with him, and he still brought his positive energy to our lab dinners and parties after he left our lab. We wish to express our condolences to Neeraj’s family, he will be dearly missed.

Read More
Yvonne Vercoulen Yvonne Vercoulen

Paper alert: T cell location in the tumor matters for dMMR colon cancer metastasis

Congratulations to Emre and Matthijs for the successful finish of their collaborative project manuscript!  A fantastic collaborative effort between the Kranenburg & Vercoulen labs with our outstanding clinical team with experts in oncology & pathology. We identified a potential spatial biomarker in primary tumor for metastasis of MSI-hi/MMRd colorectal cancer. We will follow this up in extended cohorts in new research projects,  funded by Sacha Swarttouw Hijmans Stichting. Here you can find the preprint, and the publication will come out soon @ British Journal of Cancer.                                                                                                                                                                                          Preprint: Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer                                                                                                                                                        BioRxiv 2023, DOI: 10.1101/2023.10.09.561039                                                                                                  

Read More
Yvonne Vercoulen Yvonne Vercoulen

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis

https://www.cell.com/iscience/pdf/S2589-0042(23)01968-5.pdf

Congratulations to Mick and all others who worked hard on this story, unraveling the immune cells driving toxicity (colitis) in patients treated with immune checkpoint inhibition. We show that activated, proliferating Tissue-resident memory CD8+ T cells are causing trouble in the colon.

Read More
Yvonne Vercoulen Yvonne Vercoulen

Kick-off project JAKi-MOA: unraveling JAK signaling in IBD

@matthijsbaars

We are excited to announce that Evelien Floor has initiated her PhD training and aims to unravel how JAK signaling and interference with JAK inhibitors affects cells in the gut of patients with Inflammatory Bowel Disease using Spatial Omics. Evelien will collaborate with MD/PhD candidate Jonas Louwers, and we thank Galapagos for sponsoring this collaborative project with Bas Oldenburg and Femke van Wijk.

Read More
Yvonne Vercoulen Yvonne Vercoulen

Kick-off Cocoon project

In the last months we have set the first steps of an exciting collaborative project with the teams of Monique Verstegen (Erasmus MC) and Gijsje Koenderink (TU/Delft) to unravel the tumor microenvironment of cholangiocarcinoma. We welcome Aleksandra Makowiecka, who is driving this collaboration with great enthusiasm and skill, and thank KWF Kankerbestrijding for their support!

Read More
Yvonne Vercoulen Yvonne Vercoulen

Novel review on multiplex spatial analysis in cancer

Multiplex Tissue Imaging: Spatial Revelations in the Tumor Microenvironment . van Dam S, Baars MJD, Vercoulen Y. Cancers 2022

Our review on how the latest spatial tumor microenvironment analysis has impacted cancer research and patient diagnosis/prognosis was published! read more HERE. Congratulations to Stephanie and Matthijs!

Multiplex Tissue Imaging: Spatial Revelations in the Tumor Microenvironment. Cancers 2022

Read More
Yvonne Vercoulen Yvonne Vercoulen

Structures of Strength- Gut Barrier Challenge continues!

SoS Gut Barrier Challenge

Image by: E. Floor @CMM_UMCU

SoS interdisciplinary consortium received renewal of funding from the Center for Unusual Collaborations. SoS consists of research teams from UMCU, UU, TU/e, WUR, and investigates porosity. We are happy to proceed developing innovative assays to test effects of inflammation and microbiome on the Gut Barrier, and look forward to take on this interdisciplinary Challenge!

Gut Barrier, image by Evelien Floor @UMCU

Read More
Yvonne Vercoulen Yvonne Vercoulen

T1/T17 drive Dupilumab-induced eye inflammation

Novel effective eczema drug dupilumab (IL4/IL13 blockade) can induce toxicity resulting in severe uveitis. In this collaborative study we demonstrate with multiplex IMC analysis of eye tissue that this toxic response is driven by T1/T17 inflammation. Published in Allergy last week! We thank Daphne Bakker, Femke van Wijk for a fruitful and exciting collaboration.

Bakker et al., Allergy 2021

Read More
Yvonne Vercoulen Yvonne Vercoulen

UCyTOF launched!

New year, new developments! We are announcing the launch of UCyTOF! UCyTOF will make mass cytometry technology accessible to the research community. More info HERE . Missed the kick-off seminar and would like to learn how CyTOF can help your research projects: Contact UCyTOF.

Read More
srj.agency srj.agency

RASGRP1 story Matthijs published.

Congrats to the lab and our amazing collaborators! In short: we describe a novel regulatory mechanism of RasGRP1 expression that underlies autoimmunity. Read more here.

Read More